BioWisdom announces GlaxoSmithKline to use Sofia KnowledgeScan(TM) |
 |
| Tuesday, 29 May 2007 19:00 |
|
CAMBRIDGE, UNITED KINGDOM -- May 29, 2007 -- BioWisdom Limited (BioWisdom), a leader in the development and application of Intelligence Networks for the pharmaceutical industry, today announced that GlaxoSmithKline has signed an agreement for Sofia KnowledgeScan™.
Sofia KnowledgeScan™ uses BioWisdom's powerful Sofia platform to provide unbiased and comprehensive Intelligence, to support healthcare-related decision-making for project teams. The service provides a rapid and systematic analysis of available data and is carried out by BioWisdom's healthcare analysts. "We are delighted to have this opportunity to work with GlaxoSmithKline" said Julie Barnes, CSO of BioWisdom. "We see this as further confirmation of the application of BioWisdom's Sofia technology and indeed SofiaKnowledgeScan to support business-critical decision making." Ends- Notes to Editors ABOUT BIOWISDOM BioWisdom delivers intelligence for the Healthcare Industry and helps clients to navigate the complex scientific and commercial issues involved in developing successful healthcare products. The company provides a powerful suite of software tools for the acquisition, integration, visualization and high value analysis of healthcare intelligence. The BioWisdom team combines extensive experience of the pharmaceutical and biotechnology industries with proven expertise in life science software development. For further information please visit www.biowisdom.com.
Contacts: BioWisdom Tel: +44 (0)1223 874800 Fax: +44 (0)1223 874801 Email: info@biowisdom.com Website: http://www.biowisdom.com
Melanie Toyne-Sewell / Sarah Richardson Tel: +44 (0)207 357 9477 mtoyne-sewell@hogarthpr.co.uk / srichardson@hogarthpr.co.uk
Set as favorite
Bookmark
Email this
Hits: 1545 Trackback(0)Comments (0)
|
TrackBack URI for this entry
Subscribe to this comment's feed